Addressing HIV and cervical cancer in Latin America and the Caribbean
Clinical Trials Program
This study is working to help women and children in Latin America and the Caribbean by making it easier for them to get HPV vaccinations and screenings for cervical cancer, especially in places with limited resources, while also finding the best vaccination schedules for kids living with HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11183112 on NIH RePORTER |
What this research studies
This research program aims to tackle the combined challenges of HIV infection and HPV-related cervical cancer among women and children in Latin America and the Caribbean. It focuses on improving access to HPV vaccinations and enhancing screening and treatment for cervical lesions, particularly in low-resource settings. The approach emphasizes point-of-care solutions that require minimal infrastructure, making it more feasible for local healthcare providers. The program will also evaluate the best vaccination schedules for HIV-positive children to ensure effective prevention.
Who could benefit from this research
Good fit: Ideal candidates for this research include women and children living with HIV in Latin America and the Caribbean who are at risk for HPV-associated cervical cancer.
Not a fit: Patients who are not living with HIV or who do not reside in the targeted regions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of cervical cancer and improve health outcomes for women and children living with HIV in the targeted regions.
How similar studies have performed: Previous research has shown promise in using innovative screening and vaccination strategies in low-resource settings, indicating that this approach could be effective.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Madeleine, Margaret M — Fred Hutchinson Cancer Center
- Study coordinator: Madeleine, Margaret M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.